Region
Featured experience
Atairos investment in the parent company of the Aston Villa Football Club
We are advising Atairos on the minority investment
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
$100 million investment by consortium in Airbus subsidiary AALTO
We are advising Airbus on the transaction
Haleon $3 billion secondary placing of ordinary shares
The private placement included 700,000,000 ordinary shares
Orchard Therapeutics plc Initial Public Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the…
Davis Polk Advises Tokyu Fudosan Holdings Corporation on Its ¥55.3 Billion Follow-On Equity Offering
Davis Polk advised Tokyu Fudosan Holdings Corporation in connection with a follow-on offering of 80,436,000 shares of common…
StoneCo $1.4 billion IPO and concurrent private placement
Davis Polk advised StoneCo Ltd. on its $1.4 billion initial public offering of 58,333,333 shares of Class A common stock,…
Davis Polk Advises Árima Real Estate SOCIMI, S.A. on Its €100 Million Initial Offering
Davis Polk advised Árima Real Estate SOCIMI, S.A. on the Rule 144A/Regulation S initial offering by Árima of 10,000,000 of…
Davis Polk Advises Ferguson plc on Its $750 Million Senior Notes Offering
Davis Polk advised Ferguson plc in connection with its debut Rule 144A/Regulation S offering of $750 million aggregate…
SolarWinds $375 Million Initial Public Offering
Davis Polk advised the representatives of the several underwriters in connection with an initial public offering of 25…
Studio City International Holdings Limited $359.4 Million Initial Public Offering
Davis Polk advised the representatives of the underwriters on the SEC-registered initial public offering by Studio City…
Davis Polk Advises DXC Technology Company on £450 Million Unsecured Term Loan Credit Facility
Davis Polk advised DXC Technology Company and its United Kingdom subsidiary, CSC Computer Sciences International Operations…
Davis Polk Advises Laboratorios Farmacéuticos Rovi, S.A. on Its €80 Million Follow-On Offering
Davis Polk advised Laboratorios Farmacéuticos Rovi, S.A. on its Rule 144A/Regulation S follow-on offering of 5,517,241 of…
Davis Polk Advises Sumitomo Mitsui Banking Corporation on Its $1 Billion Notes Offering
Davis Polk advised Sumitomo Mitsui Banking Corporation in connection with a global medium-term note program update and a…